Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Novacyt (ALNOV) EUR0.0667

Sell:€0.0739 Buy:€0.0769 Change: €0.0047 (5.99%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€0.0739
Buy:€0.0769
Change: €0.0047 (5.99%)
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€0.0739
Buy:€0.0769
Change: €0.0047 (5.99%)
Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Novacyt SA is a France-based company that develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The Company develops a secure automated cytology named NovaPrep Processor System. Novacyt SA offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The Company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle. Novacyt SA is present in France and internationally through a network of over 10 distributors.

Contact details

Address:
13 avenue Morane Saulnier
VELIZY VILLACOUBLAY
78140
France
Telephone:
+33 (1) 39465104
Website:
https://novacyt.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ALNOV
ISIN:
FR0010397232
Market cap:
€3.75 million
Shares in issue:
37.66 million
Sector:
Biotechnology
Exchange:
Euronext Paris
Country:
France
Currency:
Euro
Indices:
n/a

Key personnel

  • Graham Mullis
    Chief Executive Officer, Executive Director, Member of the Executive Team
  • Anthony Dyer
    Chief Financial Officer, Executive Director, Company Secretary, Member of the Executive Team
  • Wendy Karban
    Member of the Executive Team, Group Human Resource Manager
  • Mandy Cowling
    Member of the Executive Team, Corporate & Investor Relations Manager
  • Paul Eros
    Member of the Executive Team, Managing Director Primerdesign Division
  • Steve Gibson
    Member of the Executive Team, Group Financial Controller
  • Ruth Powell
    Member of the Executive Team, Managing Director NOVAprep Division
  • Phillip Sefton
    Member of the Executive Team, Managing Director Lab21 Division
  • Ian Wilde
    Member of the Executive Team, Group RA & QA Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.